Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ariane Osterwald, D.O.

Concepts (12)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ariane Osterwald's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ariane Osterwald has written about over time.
Brain, 1 publications between 2022 and 2022, average publication date November 2022. Diffuse Axonal Injury, 1 publications between 2022 and 2022, average publication date November 2022. Hemiplegia, 1 publications between 2022 and 2022, average publication date November 2022. Magnetic Resonance Imaging, 1 publications between 2022 and 2022, average publication date November 2022. Humans, 3 publications between 2022 and 2023, average publication date December 2022. Adolescent, 1 publications between 2023 and 2023, average publication date January 2023. Artificial Intelligence, 1 publications between 2023 and 2023, average publication date January 2023. Genetic Predisposition to Disease, 1 publications between 2023 and 2023, average publication date January 2023. Hemipelvectomy, 1 publications between 2023 and 2023, average publication date January 2023. Li-Fraumeni Syndrome, 1 publications between 2023 and 2023, average publication date January 2023. Technology, 1 publications between 2023 and 2023, average publication date January 2023. Tumor Suppressor Protein p53, 1 publications between 2023 and 2023, average publication date January 2023.

To see the data from this visualization as text, click here.
Osterwald's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.